Susan L. Main joined Ashland’s board in July 2017 and serves on the audit committee and the governance and nominating committee. Ms. Main served as the Senior Vice President and Chief Financial Officer of Teledyne Technologies Incorporated, a leading provider of advanced technology and high reliability products for the aerospace and defense, factory automation, air and water quality environmental monitoring, electronics design and development, oceanographic research, deepwater oil and gas exploration and production, medical imaging and pharmaceutical research markets, from 2012 to 2023. Prior to that, she was Vice President and Controller of Teledyne, a position she held for eight years. From 1999 to 2004, Ms. Main served as Vice President and Controller for Water Pik Technologies, Inc. She also held numerous financial roles at the former Allegheny Teledyne Incorporated in its government, industrial and commercial segments. Earlier in her career, Ms. Main held financial and auditing roles at the former Hughes Aircraft Company. She is a graduate of California State University, Fullerton.

Janice J. Teal, Ph.D., former group vice president and chief scientific officer for Avon Products Inc., was elected to the company’s board of directors in September 2012. Dr. Teal serves as chair of the Environmental, Health, Safety and Quality Committee and a member of the Compensation Committees. She brings 28 years of leadership and scientific research experience to Ashland’s board. Prior to her retirement from Avon in 2010, she led the company’s global research and development team of chemists and scientists, with responsibility for the development and support of Avon’s worldwide product lines. Before that, Dr. Teal served as vice president of the Avon Skin Care Laboratories, where she led the bioscience research and skin care teams that ultimately led to the growth of the Anew Skin Care brand to over $1 billion in sales. She had additional responsibility for development of Avon’s vitamin and nutritional lines. Dr. Teal joined Avon in 1982 as a program leader in toxicology and built Avon’s first pharmacokinetics and cell culture laboratories. She earned a Ph.D. in pharmacology from Emory University and served as a Research Fellow in toxicology at New York University. She previously served on the board of directors of Arch Chemicals, which was acquired last year by Lonza Group Ltd.

Mr. Willis, was elected senior vice president and chief financial officer of Ashland  in 2013. He oversees Ashland's worldwide financial functions and processes, including financial accounting and reporting, treasury and finance, insurance, business development, planning and analysis, investor relations, tax and internal audit activities. A member of Ashland's Executive Committee, he shares overall responsibility for setting Ashland's global strategy, managing capital, and upholding Ashland's operating principles.
  
Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Spending nearly three years in The Netherlands, he helped lead Ashland's effort to standardize processes and implement accounting and other administrative shared services across European operations.

In 2004, Willis was designated general auditor. Later in 2007, he was appointed vice president and treasurer of Ashland. Since Ashland's acquisition of International Specialty Products (ISP) in August 2011, Willis served as Ashland's vice president of finance, and controller for Ashland Specialty Ingredients, Ashland's largest and fastest-growing commercial unit. He was responsible for the day-to-day management of the financial organization and processes within Specialty Ingredients and served on the leadership team.

A native of Richmond, Ky., Kevin earned a bachelor’s degree in accounting from Eastern Kentucky University and an MBA from the Kellogg School of Management at Northwestern University.

George Schaefer, 68, has been a director of Ashland since 2003 and serves as chair of the Audit Committee and a member of the Compensation Committee.

Mr. Schaefer retired as chairman of the board of Fifth Third Bancorp in 2008, having previously served Fifth Third as chief executive officer, president and chief operating officer during his tenure. He is a director of Wellpoint Inc. He also serves as a member of the board of trustees of the University of Cincinnati Healthcare System.